Finland· FI-REL-REL44087
Imatinib Actavis
A imatinib product containing imatinib mesylate, registered in Finland by Actavis Group PTC ehf. The same ATC class is registered in 15 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Imatinib is registered in 15 of 19 countries.
Countries holding a registration under ATC L01EA01 (imatinib), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Imatinib · ATC L01EA01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of imatinib costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $2.80 in United States to $41.72 in Switzerland — a ×15 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Imatinib · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$41.72
- IT Italy$11.38
- US United States$2.80 (acquisition cost)
The record
At a glance
Fimea (Finland)- Active substance
- Imatinib mesylate
- Manufacturer
- Actavis Group PTC ehf
- Country
- Finland (FI)
- ATC code
- L01EA01
- ATC class
- Imatinib
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
766 interactions on record for imatinib.
Graded by severity as the source publishes them — 114 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Imatinib · interactions on record
766 records
- 114 severe
- 518 moderate
- 23 minor
- 111 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- EliglustatA16AX10severe
- LonafarnibA16AX20severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Imatinib in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIMATINIB TEVATeva B.V., Haarlem
- BelgiumImatinib Actavis 400 mgActavis Group PTC
- PolandImatilekPrzedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.
- SwedenImatinib Actavis 400 mg Kapsel, hårdActavis Group PTC ehf.
- SpainIMATINIB ALTAN 400 MG CAPSULAS DURAS EFGAltan Pharmaceuticals Sa
- United KingdomImatinib 400mg capsulesCipla EU Ltd
- DenmarkImatinib "Stada"STADA Arzneimittel AG
- IcelandImatinib TevaTeva B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Imagerolan, Imatinib 1a Pharma
- Belgium · Imatinib Eg, Imatinib Grindeks
- Bulgaria · Иматиниб Тева Фарма, Меаксин
- Cyprus · Imarem, Imatinib Koanaa 100 Mg
- Czechia · Imanivec, Imatinib Grindeks
- Germany · Imanivec, Imatinib 1 A Pharma
- Denmark · Bimatix, Imatinib "sandoz"
- Estonia · Glipox, Imatinib Grindeks
- Spain · Imatinib Cipla, Imatinib Farmalider
- France · Imatinib Arrow Lab, Imatinib Bgr
- United Kingdom (Northern Ireland) · Imatinib, Imatinib Amarox
- Greece · Imatek, Imatinib Aenorasis
- Croatia · Imakrebin, Meaxin
- Hungary · Imaniver, Imatinib 1 A Pharma
- Ireland · Imatinib Krka D.D., Imatinib Rowex
- Iceland · Bimatix, Glivec
- Italy · Imanivec, Imatinib Dr. Reddy’s
- Liechtenstein · Glivec, Imatinib Accord
- Lithuania · Glipox, Imatinib Grindeks
- Luxembourg · Imatinib, Imatinib Eg
- Latvia · Imatinib Grindeks, Imatinib Inteli
- Malta · Imatinib Tad, Nibix
- Netherlands · Bimatix, Imakrebin
- Norway · Bimatix, Glivec
- Poland · Imatenil, Meaxin
- Portugal · Imatinib Aurobindo, Imatinib Aurovitas
- Romania · Imakrebin, Imatinib Grindeks
- Sweden · Bimatix, Imatinib Amarox
- Slovenia · Meaxin
- Slovakia · Imatinib Glenmark, Imatinib Grindeks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8a047836-5bf1-4d16-ba85-285409fce311 GET /v1/drugs/8a047836-5bf1-4d16-ba85-285409fce311?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.4",
"form": "kapseli, kova",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "400 mg",
"atc_label": "imatinibi",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/13/825/020-023",
"fimea_rel_id": "REL44087",
"authorised_at": "2014-06-12"
}See everything about imatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.